期刊文献+

坎地沙坦联合辛伐他汀对高胆固醇血症高血压患者血管内皮功能的影响 被引量:15

Effects of combined therapy with simvastatin and candesartan on vasodilatation function in patients with hypertension and hypercholesterol
下载PDF
导出
摘要 目的观察他汀类调脂药物辛伐他汀联合使用血管紧张素Ⅱ受体拮抗剂(ARB)坎地沙坦对伴有高胆固醇血症的高血压患者血管内皮功能和炎症因子的影响。方法采用自身对照研究,给予46例伴有高胆固醇血症的高血压患者坎地沙坦4mg/d结合膳食治疗,8周后加服辛伐他汀每晚20mg。服药治疗前、8周以及16周结束时采用高分辨率超声系统检测肱动脉血流介导的血管舒张反应(FMD)评价血管内皮功能,并抽血比较血胆固醇、三酰甘油、低密度脂蛋白(LDL)、高密度脂蛋白(HDL)、血糖、血胰岛素、高敏C反应蛋白水平变化。结果坎地沙坦可以显著降低血压,加服辛伐他汀后血脂明显下降,血压没有进一步下降。联合治疗较单用坎地沙坦能进一步改善内皮依赖的血管舒张功能。结论辛伐他汀联合应用血管紧张素Ⅱ受体拮抗剂坎地沙坦可以进一步改善伴有高胆固醇血症的高血压患者的内皮功能。 Objective To observe the effect of combined therapy with simvastatin and candesartan on endothelium function and inflammation factor and the blood pressure control in the patients with hypertension and hypercholesterol. Methods Forty-six cases with hypertension and hypercholesterol were received candesartan 4mg per day and dietary therapy in a self-controlled study, then simvastatin 20mg per night was added as combined therpy after 8 weeks. The noninvasive ultrasonic examination was used to observe the changes of brachial artery diameter during baseline, reactive hyperemia and sublingual nitroglycerin administration, flow mediated vasodilatation(FMD) and nitroglycerin mediated vasodilatation(NMD). Blood pressure, plasma cholesterol, plasma tri- glyceride,insulin,blood glucose and C-reaction protein were also measured at 0,8,16 weeks. Results The levels of blood pressure were decreased significantly at 8 week after using candesartan(P〈0.01), combined therapy could not decrease the levels of blood pressure further. But combined therapy significantly improved flow-mediated dilator response to hyperemia compared with candesartan alone(P〈0.05). Conclusion The use of simvastatin in combination with candesartan improves endothelial function in hypercholesterolemic and hypertensive patients.
出处 《重庆医学》 CAS CSCD 北大核心 2010年第2期180-182,共3页 Chongqing medicine
关键词 辛伐他汀 坎地沙坦 高血压 高胆固醇血症 血管舒张 simvastatin candesartan hypertension hypercholesterol vasodilatation
  • 相关文献

参考文献12

  • 1Cosentino F, Voljpe M. Hypertehsion, stroke, and endothelium[J]. Curr Hypertens Rep, 2005,7 ( 1 ) : 68.
  • 2刘力生主编.中国高血压防治指南(2005年修订版)[M].北京:人民卫生出版社,2005.20-30.
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5227
  • 4Celermajer DS..Sorensen KE,Gooch VM, et al. Non inva sive detection of endothelial dysfunction in children and adults at risk of atherosclerosis [J]. Lancet, 1992, 340 :1111.
  • 5Perticone F, Sciacqua A, Maio R, et al. A symmetric dimethylarginine, L-arginine, and endot helial dysfunction in essential hypertension[J].J Am Coll Cardiol, 2005, 46 (3):518.
  • 6Nickenig G, Sachinidis A, Michaelsen F, et al. Upregulation of vascular angiotensin-II receptor gene expression by low-density lipoproytein in vascular smooth muscule cells[J]. Circulation, 1997,95:473.
  • 7Niekenig G, Jung O , Strehlow K, et al. Hypercholesterolemia is associated with enhanced angiotensin AT1-rreceptot expression[J]. Am J Physiol,1997,272. H2701.
  • 8Wang CH, Li SH,Weisel RD, et al. C-reactive, protein upregulates angiotensin type 1 receptors in vascular smooth muscle[J]. Circulation, 2903,107 : 1783.
  • 9Kaesemeyer WH, Caldwell RB, Huang J, et al..Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lwering actions[J]. J Am Coll Cardiol, 1999,33(1) :234.
  • 10Hernandez TL,Capell WH ,Wolfe P, et al. Time course of C-reactive protein reduction with simvastatin therapy in patients with type 2 diabetes mellitus[J]. Am J Cardiol, 2006 ,98(12) : 1656.

二级参考文献149

共引文献5276

同被引文献101

引证文献15

二级引证文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部